-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Trevi Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2018 to 2024.
- Trevi Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$8 K, a 14.3% decline year-over-year.
- Trevi Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was -$33 K, a 13.2% increase year-over-year.
- Trevi Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was -$32 K, a 11.1% increase from 2022.
- Trevi Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was -$36 K, a 71.4% decline from 2021.
- Trevi Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was -$21 K, a 16.7% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)